Dr Fadi-jean Saad, MD - Medicare Pulmonary Disease in Roseville, MI

Dr Fadi-jean Saad, MD is a medicare enrolled "Internal Medicine - Pulmonary Disease" physician in Roseville, Michigan. He graduated from medical school in 1996 and has 28 years of diverse experience with area of expertise as Pulmonary Disease. He is a member of the group practice Emad Alatassi Md, P.c. and his current practice location is 18263 E 10 Mile Rd, Suite D, Roseville, Michigan. You can reach out to his office (for appointments etc.) via phone at (586) 778-3478.

Dr Fadi-jean Saad is licensed to practice in Michigan (license number 4301087234) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1174573810.

Contact Information

Dr Fadi-jean Saad, MD
18263 E 10 Mile Rd, Suite D,
Roseville, MI 48066-5805
(586) 778-3478
(586) 778-3496



Physician's Profile

Full NameDr Fadi-jean Saad
GenderMale
SpecialityPulmonary Disease
Experience28 Years
Location18263 E 10 Mile Rd, Roseville, Michigan
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Fadi-jean Saad graduated from medical school in 1996
  NPI Data:
  • NPI Number: 1174573810
  • Provider Enumeration Date: 05/11/2006
  • Last Update Date: 01/13/2010
  Medicare PECOS Information:
  • PECOS PAC ID: 0143232827
  • Enrollment ID: I20060620000324

Medical Identifiers

Medical identifiers for Dr Fadi-jean Saad such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1174573810NPI-NPPES
487600010MedicaidMI

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207RP1001XInternal Medicine - Pulmonary Disease 4301087234 (Michigan)Primary
207RC0200XInternal Medicine - Critical Care Medicine 4301087234 (Michigan)Secondary
207RS0012XInternal Medicine - Sleep Medicine 4301087234 (Michigan)Secondary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Beaumont Hospital, TroyTroy, MIHospital
Ascension Macomb Oakland Hosp-warren CampusWarren, MIHospital

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Fadi-jean Saad allows following entities to bill medicare on his behalf.
Entity NameEmad Alatassi Md, P.c.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1447457734
PECOS PAC ID: 6204860463
Enrollment ID: O20050927000225

News Archive

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

Forensic experts need statistical models to give weight to DNA-evidence

How do forensic scientists deal with complex DNA-evidence found at crime scenes? Giulia Cereda developed new statistical models to analyse them.

Tobira completes $31 million Series B financing

Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral compounds to treat HIV disease, today announced the completion of a $31 million Series B financing. New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.

Read more Medical News

› Verified 2 days ago

Entity NameFadi-jean Saad Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1801552708
PECOS PAC ID: 1759772668
Enrollment ID: O20220104002120

News Archive

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

Forensic experts need statistical models to give weight to DNA-evidence

How do forensic scientists deal with complex DNA-evidence found at crime scenes? Giulia Cereda developed new statistical models to analyse them.

Tobira completes $31 million Series B financing

Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral compounds to treat HIV disease, today announced the completion of a $31 million Series B financing. New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Fadi-jean Saad is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Fadi-jean Saad, MD
18263 E 10 Mile Rd, Suite D,
Roseville, MI 48066-5805

Ph: (586) 778-3478
Dr Fadi-jean Saad, MD
18263 E 10 Mile Rd, Suite D,
Roseville, MI 48066-5805

Ph: (586) 778-3478

News Archive

Findings explain molecular mechanisms underlying microvascular disease in diabetes patients

Patients with diabetes are at increased risk of microvascular complications, which develop when the body's small blood vessels become diseased. One of the most common problems results when wounds fail to heal properly, which can lead to ulcers, chronic infections, and in the most serious cases, limb amputations.

Development of lab-on-chip system for breast cancer detection and therapy

IMEC, a leading European research center in nanotechnology, the Institüt für Mikrotechnik Mainz (IMM), one of the leading European research centers in microfluidics, and their partners within the European Sixth Framework Project MASCOT achieve a major milestone in the development of a lab-on-chip for the detection and therapy evaluation of breast cancer.

Astellas, AVEO enter development, commercialization agreement for tivozanib

Astellas Pharma Inc., a global pharmaceutical company, and AVEO Pharmaceuticals, Inc. today announced that they have entered into a worldwide agreement outside of Asia to develop and commercialize tivozanib, AVEO's lead product candidate designed to optimally block the VEGF pathway by inhibiting all three VEGF receptors, for the treatment of a broad range of cancers.

Forensic experts need statistical models to give weight to DNA-evidence

How do forensic scientists deal with complex DNA-evidence found at crime scenes? Giulia Cereda developed new statistical models to analyse them.

Tobira completes $31 million Series B financing

Tobira Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative antiviral compounds to treat HIV disease, today announced the completion of a $31 million Series B financing. New investor Novo A/S is leading the round, joined by original investors, Domain Associates, L.L.C., Frazier Healthcare Ventures, Montreux Equity Partners and Canaan Partners.

Read more News

› Verified 2 days ago


Internal Medicine Doctors in Roseville, MI

Robert Lewis Marchese, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 25810 Kelly Rd, Suite 3, Roseville, MI 48066
Phone: 586-777-9724    Fax: 586-777-9725
Benjamin O Osowa, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18263 E 10 Mile Rd, Suite E, Roseville, MI 48066
Phone: 586-552-8696    Fax: 586-552-4404
Dr. Majid Alzagoum, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066
Phone: 586-776-8877    Fax: 586-776-3092
Dr. Wahed Ishaqsei, M.D.
Pulmonary Disease
Medicare: May Accept Medicare Assignments
Practice Location: 18263 E 10 Mile Rd, Suite D, Roseville, MI 48066
Phone: 586-778-4950    Fax: 586-778-4952
Dr. Mohamad K. Ajjour, M.D.
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18303 E 10 Mile Rd, Suite 100, Roseville, MI 48066
Phone: 586-776-8877    Fax: 586-776-3092
Dr. Ameer Abdulrazzak, MD
Pulmonary Disease
Medicare: Accepting Medicare Assignments
Practice Location: 18001 E 10 Mile, Suite 1, Roseville, MI 48066
Phone: 586-218-5800    Fax: 586-218-5808
Dr. Madjid Mesgarzadeh, MD
Pulmonary Disease
Medicare: Not Enrolled in Medicare
Practice Location: 25910 Kelly Rd, Suite B, Roseville, MI 48066
Phone: 586-772-3366    Fax: 586-772-3355

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.